GaryJayBrennerMDPhysician Scientist
Anesthesiology • Boston, MAPain Medicine
Program Director, Pain Medicine Fellowship - Massachusetts General Hospital; Associate Professor - Harvard Medical School.
Dr. Brenner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MGH Center for Pain Medicine, WAC 334
15 Parkman Street
Boston, MA 02114Phone+1 617-726-9223Fax+1 617-724-3632
Education & Training
Massachusetts General HospitalFellowship, Pain Medicine, 1999 - 2000- Massachusetts General HospitalResidency, Anesthesiology, 1996 - 1999
Highland Hospital of RochesterInternship, Internal Medicine, 1995 - 1996
University of Rochester School of Medicine and DentistryPh.D., Microbiology & Immunology, 1991 - 1995
University of Rochester School of Medicine and DentistryClass of 1995- Wesleyan UniversityBA, Biology, 1982 - 1986
Certifications & Licensure
MA State Medical License 1999 - 2027
American Board of Anesthesiology Pain Medicine
Awards, Honors, & Recognition
- Boston Magazine - Top Doc in Pain Medicine Castle Connelly, 2010-2021
Publications & Presentations
PubMed
- Culture of attenuatedTyphimurium VNP20009 in animal-product-free media does not alter schwannoma growth control.Sherif G Ahmed, Giulia Oliva, Manlin Shao, John J Mekalanos, Gary J Brenner
Human Vaccines & Immunotherapeutics. 2023-08-01 - 2 citationsComparative Transcriptomic Analysis of Archival Human Vestibular Schwannoma Tissue from Patients with and without Tinnitus.Krishna Bommakanti, Richard Seist, Phanidhar Kukutla, Murat Cetinbas, Shelley Batts
Journal of Clinical Medicine. 2023-04-01 - 3 citationsEffect of Antibiotic Treatment on AttenuatedVNP20009 Mediated Schwannoma Growth Control.Sherif G Ahmed, Gary J Brenner
Anticancer Research. 2023-01-01
Press Mentions
Crowdsourcing to Fund Rare Disease ResearchJuly 6th, 2019
Patient Story: Karen EnglishApril 22nd, 2019
Mom Blazes Path to Cure for Son’s Rare DiseaseFebruary 27th, 2019
Grant Support
- Salmonella typhimurium-based Bacteriotherapy for Orphan Benign Tumors: Neurofibromatosis Type II (NF2)NIH - NINDS2019–Present
- Translation of AAV P0 ICE schwannoma gene therapy to clinical TrialsNIH2015–2018
- Mechanisms of caspase-1 mediated schwannoma regressionNIH2012–2017
- NMDA Receptor Phosphorylation And Trafficking After PainNational Institute Of Neurological Disorders And Stroke2002–2006
- Department Of Microbiology And ImmunologyNational Institute Of Mental Health1991–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
